Selective Serotonin Reuptake Inhibitors, Venlafaxine and Duloxetine are Associated With in Hospital Morbidity but Not Bleeding or Late Mortality After Coronary Artery Bypass Graft Surgery
Authors:
- Phillip J. TullyPTPhillip J. Tully
- Tess CardinalTCTess Cardinal
- Jayme S. BennettsJBJayme S. Bennetts
- Robert A. BakerRBRobert A. Baker
- 1 April 2012
- journal article
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 21 (4) , 206-214
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarctionCanadian Medical Association Journal, 2011
- The puzzle of depression and acute coronary syndrome: Reviewing the role of acute inflammationJournal of Psychosomatic Research, 2011
- Meta-Analysis of Selective Serotonin Reuptake Inhibitors in Patients With Depression and Coronary Heart DiseaseThe American Journal of Cardiology, 2011
- High mortality among heart failure patients treated with antidepressantsInternational Journal of Cardiology, 2011
- Safety of Selective Serotonin Reuptake Inhibitor in Adults Undergoing Coronary Artery Bypass GraftingThe American Journal of Cardiology, 2009
- Adverse Hospital Events for Mentally Ill Patients Undergoing Coronary Artery Bypass SurgeryHealth Services Research, 2008
- Prediction of massive blood transfusion in cardiac surgeryCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2006
- Prognosis of Patients Taking Selective Serotonin Reuptake Inhibitors Before Coronary Artery Bypass GraftingThe American Journal of Cardiology, 2006
- Perioperative Management for Chronic Schizophrenic PatientsAnesthesia & Analgesia, 2005
- Depression and Medication Adherence in Outpatients With Coronary Heart DiseaseArchives of internal medicine (1960), 2005